Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

71.28
+0.08000.11%
Volume:8.99M
Turnover:640.10M
Market Cap:105.67B
PE:36.74
High:71.94
Open:70.73
Low:70.12
Close:71.20
52wk High:109.50
52wk Low:67.56
Shares:1.48B
Float Shares:1.48B
Volume Ratio:0.77
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.94
EPS(LYR):1.94
ROE:12.45%
ROA:5.98%
PB:4.36
PE(LYR):36.74

Loading ...

Boston Scientific Faces Investor Lawsuit Alleging Misleading Statements About Electrophysiology Growth

TIPRANKS
·
14 hours ago

Boston Scientific Is Maintained at Buy by Truist Securities

Dow Jones
·
15 hours ago

Class Action Lawsuit Targets Boston Scientific Over Alleged Securities Law Violations

Reuters
·
16 hours ago

Eli Lilly, Stryker and Other Healthcare Stocks Are Ready to Bounce. Why They Look Like Buys. -- Barrons.com

Dow Jones
·
Yesterday

Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), Boston Scientific (BSX)

TIPRANKS
·
Yesterday

Boston Scientific price target lowered to $92 from $95 at Truist

TIPRANKS
·
Yesterday

Truist Cuts Price Target on Boston Scientific to $92 From $95, Keeps Buy Rating

MT Newswires Live
·
Yesterday

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

Boston Scientific Is Maintained at Buy by UBS

Dow Jones
·
Yesterday

Abbott Laboratories' Structural Heart Business Could See Upside From Watchman Trial Results, UBS Says

MT Newswires Live
·
Mar 13

Elutia Q4 revenue rises on higher cardiovascular product sales

Reuters
·
Mar 12

Boston Scientific Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 11

Boston Scientific price target lowered to $94 from $102 at Citi

TIPRANKS
·
Mar 11

Baird Adjusts Price Target on Boston Scientific to $95 From $101, Maintains Outperform Rating

MT Newswires Live
·
Mar 11

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

Reuters
·
Mar 11

Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 11

Boston Scientific Targets Drug-Resistant Motor Epilepsy With New Deep Brain Stimulation Trial

TIPRANKS
·
Mar 11

Boston Scientific (BSX): CHAMPION AF Trial Poised to Strengthen Watchman Evidence, Broaden Adoption, and Support Buy Rating

TIPRANKS
·
Mar 09

Class Action Lawsuit Targets Boston Scientific Over Alleged Investor Harm

Reuters
·
Mar 09

Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention

TIPRANKS
·
Mar 07